TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 107 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,778,102 | +27.9% | 100,062 | +30.0% | 0.00% | – |
| Q2 2023 | $1,390,523 | +287.3% | 76,952 | +169.4% | 0.00% | – |
| Q1 2023 | $359,062 | -56.0% | 28,565 | -48.7% | 0.00% | – |
| Q4 2022 | $816,092 | -56.2% | 55,668 | -48.8% | 0.00% | – |
| Q3 2022 | $1,862,000 | +29.2% | 108,728 | +10.1% | 0.00% | – |
| Q2 2022 | $1,441,000 | +203.4% | 98,710 | +249.3% | 0.00% | – |
| Q1 2022 | $475,000 | -24.8% | 28,256 | +0.5% | 0.00% | – |
| Q4 2021 | $632,000 | +10.7% | 28,103 | +6.1% | 0.00% | – |
| Q3 2021 | $571,000 | -26.7% | 26,480 | -1.5% | 0.00% | – |
| Q2 2021 | $779,000 | -16.6% | 26,880 | -7.3% | 0.00% | – |
| Q1 2021 | $934,000 | – | 28,994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |